Drugs / INA03
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03957915 | May 2020 → Jul 2024 | acute lymphoblastic leukemia, mixed phenotype acute leukemia | Institut Paoli-Calmettes | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INA03 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03957915 ↗ |
| Route | Intravenous | “INA03 administered as a single agent IV infusion every 2 weeks” NCT03957915 ↗ |